This would contribute to the ongoing systematic effort to provide an evidence base for the utility and priority of genomic applications in public health [107], [108]. (genomemedicine.biomedcentral.com)
One of the barriers to realizing this mission is a health professional workforce that is not prepared to use genomic applications in patient care. (jax.org)
BERKELEY, CA, and CORALVILLE, IA — February 23, 2016 — Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc. (IDT), a producer of custom synthetic oligonucleotide - based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR - Cas9 reagents under Caribou's intellectual property. (cariboubio.com)